ISOLATED PEPTIDE, ISOLATED POLYNUCLEOTIDE ENCODING IT, ISOLATED CONJUGATE OF THE PEPTIDE, AND PHARMACEUTICAL COMPOSITION COMPRISING IT

AR105485B1Active Publication Date: 2026-08-26HANMI PHARM CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20160101975
Authority / Receiving Office: AR · AR
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2015-06-30
Filing Date: 2016-06-29
Publication Date: 2026-08-26
Estimated Expiration: 2036-06-29

Application Information

Patent Timeline

30 Jun 2015

Priority

29 Jun 2016

Application

ARP20160101975

26 Aug 2026

Publication

AR105485B1

IPC: C07K14/605; C12N15/18; C12N15/63; A61K38/26; A61K38/28

Inventors: LEE, JONG SUK; LEE, JONG MIN

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Development of glucagon variants to improve therapeutic effects in hypoglycemia and obesity. These glucagon variants exhibit high solubility and stability at neutral pH.

Need to check novelty before this filing date? Find Prior Art

Claims

1. An isolated peptide, characterized in that it comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 2 to 11 and 13 to 44. 16 Claims follow